Skip to content

Effects of consumption of the Mallotus japonicus leaf extract powder on skin in healthy Japanese subjects

Effects of consumption of the Mallotus japonicus leaf extract powder on skin in healthy Japanese subjects: a randomized, placebo-controlled, double-blind, parallel-group comparison study - Effects of consumption of the Mallotus japonicus leaf extract powder on skin in healthy Japanese subjects

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000051165
Enrollment
20
Registered
2024-09-16
Start date
2023-05-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Japanese subjects

Interventions

Duration: Eight weeks Test food: Capsule containing Mallotus japonicus leaf extract powder Administration: Take one capsule per day after breakfast with water *If you forget to take the test food

Sponsors

ORTHOMEDICO Inc.
Lead Sponsor
Medical Corporation Seishinkai, Takara Clinic Nerima Medical Association, Minami-machi Clinic
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Japanese 2. Women 3. Adults 4. Healthy subjects 5. Subjects who feel a decline in skin moisture

Exclusion criteria

Exclusion criteria: 1. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Subjects currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4. Subjects who use or take "Foods for Specified Health Uses," or "Foods with Functional Claims" in daily 5. Subjects who are currently taking medications (including herbal medicines) and supplements 6. Subjects who are allergic to medicines and/or the test food related products 7. Subjects who are pregnant, lactating, or planning to become pregnant during this trial 8. Subjects who have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial 9. Subjects who are currently using medications or other products that may affect the skin, such as medicinal lotions 10. Subjects who take foods or supplements that may affect the skin, such as procyanidins, sodium hyaluronate, or glucosylceramide 11. Subjects who regularly take supplements with rich ellagitannins such as pomegranate, guava, and "Ten-Cha" (sweet Chinese tea) 12. Subjects who take foods or supplements that may affect blood flow, such as elastin, chlorogenic acid 13. Subjects who engage in occupations involving outdoor work 14. Subjects who plan to take trips that will expose them to a lot of sunlight, such as swimming in the sea during this trial 15. Subjects who are judged as ineligible to participate in this study by the physician

Design outcomes

Primary

MeasureTime frame
1. The moisture of the skin, transepidermal water loss, and viscoelasticity of the skin

Secondary

MeasureTime frame
1. The score of advanced glycation end products (AGEs), oxidative stress, blood flow volume, and original questionnaires

Countries

Japan

Contacts

Public ContactNaoko Suzuki

ORTHOMEDICO Inc. R&D Department

nao@orthomedico.jp03-3818-0610

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026